Copyright © 1991 by the European Society of Cardiology.
© 1991 The European Society of Cardiology
Thirty-day mortality after valve replacement for aortic stenosis over the last 22 years. A multivariate risk stratification
Department of Thoracic and Cardiovascular Surgery and Department of Cardiology, Skejby Sygehus, Aarhus University Hospital DK-8200 Aarhus N, Denmark
Received 13 December 1989; revised 5 June 1990; .
Correspondence: Ole Lund, MD, Department of Thoracic and Cardiovascular Surgery. Skejby Sygehus, Aarhus University Hospital, Brendstrupgaardsvej, DK-8200 Aarhus N, Denmark.
Abstract
Over the last 22 years (1965–86), the 30-day mortality rate (30-DMR) after valve replacement for primary or predominant aortic stenosis (AS, N = 690) fell from 20.0% for the first 100 consecutive patients, via 7.8% for the next 490, to 2.0% for the final 100 (P < 00001). There was, however, a wide scatter in 30-DMR in the 11 consecutive 2-year periods, as well as during later years. The variation in 30-DMR was paralleled by changes in a high risk prognostic index (derived from a logistic regression model) and in a high coronary artery disease (CAD) score. In patients with a high CAD score who died within 30 days, 93% (N = 25) had CAD at autopsy compared with 37% (N = 11) of those with a low CAD score (P<0.0001). In 205 patients evaluated by coronary arteriography, the 30-DMR was 41% in 122 without CAD, 3.6% (3.8% for triple vessel/left main stem) for 55 with CAD who underwent bypass grafting, and 17.9% for 28 with CAD who did not have bypass grafting (P<0.0001). Left ventricular failure (LVF; episodes of pulmonary oedema and/or stasis), age, pronounced hypertrophy/strain in the ECG, and a high CAD score were independent incremental risk factors for 30-DMR. Quantitatively, LVF increased the risk 10 times more than pronounced hypertrophy /strain and a high CAD score. LVF also neutralized the influence of age. Modifying (symptom-masking) digitalis and/or diuretic treatment in functional class II patients (N = 189) increased the 30-DMR from 0.9% to 9.1% (P<0.01).
The scatter of operative year-specific 30-DMR was related to changes in preoperative prognostic patient profiles and to unrevascularized CAD. Operative intervention in AS patients, even with discrete symptoms, and consistent revascularization of significant CAD, should be strongly advocated.
Key Words: Aortic valve stenosis • heart valve replacement • 30-day mortality • operative mortality • risk stratification
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Gaudino, F. Alessandrini, F. Glieca, N. Luciani, C. Cellini, C. Pragliola, M. Morelli, C. Canosa, G. Nasso, and G. Possati Survival after aortic valve replacement for aortic stenosis: does left ventricular mass regression have a clinical correlate? Eur. Heart J., January 1, 2005; 26(1): 51 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hellgren, P. Kvidal, and E. Stahle Improved early results after heart valve surgery over the last decade Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 904 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.M Grocott-Mason, O Lund, H Elwidaa, R Mazhar, V Chandrasakeran, A.G Mitchell, C Ilsley, A Khaghani, A Rees, and M Yacoub Long-term results after aortic valve replacement in patients with congestive heart failure. Homografts vs prosthetic valves Eur. Heart J., October 2, 2000; 21(20): 1698 - 1707. [Abstract] [PDF]
|
|
|
|
 |
|
 E. L. Hannan, M. J. Racz, R. H. Jones, J. P. Gold, T. J. Ryan, J.-P. Hafner, and O. W. Isom Predictors of mortality for patients undergoing cardiac valve replacements in New York State Ann. Thorac. Surg., October 1, 2000; 70(4): 1212 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J.O. Birkmeyer, C. A.S. Marrin, J. R. Morton, B. J. Leavitt, S. J. Lahey, D. C. Charlesworth, F. Hernandez, E. M. Olmstead, and G. T. O'Connor Decreasing mortality for aortic and mitral valve surgery in northern New England Ann. Thorac. Surg., August 1, 2000; 70(2): 432 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Collinson, M. Henein, M. Flather, J. R. Pepper, and D. G. Gibson Valve Replacement for Aortic Stenosis in Patients With Poor Left Ventricular Function : Comparison of Early Changes With Stented and Stentless Valves Circulation, November 9, 1999; 100(90002): II-1 - 5. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.R. E. Jamieson, F. H. Edwards, M. Schwartz, J. W. Bero, R. E. Clark, and F. L. Grover Risk stratification for cardiac valve replacement. National Cardiac Surgery Database Ann. Thorac. Surg., April 1, 1999; 67(4): 943 - 951. [Abstract] [Full Text] [PDF]
|
|